David M. Simpson

Papers

Total Citations

H-Index

About

David M. Simpson is a leading clinical researcher whose work centers on neuromuscular disorders, neuropathic pain, and the neurological complications of HIV/AIDS. He is best known for pioneering the use of botulinum toxin in treating spasticity and dystonia, fundamentally shifting the understanding of spastic paresis from a mere symptom to a treatable movement disorder. His most-cited paper, "Spastic Paresis: A Treatable Movement Disorder" (2024, 16 citations), redefines the condition as an archetypical movement disorder, advocating for its inclusion within the broader neurological sphere. This conceptual breakthrough has opened new avenues for targeted therapies. With over 300 peer-reviewed publications and an h-index exceeding 60, Simpson's work has garnered thousands of citations, reflecting his profound impact on clinical practice. He has also been instrumental in developing evidence-based guidelines for the management of HIV-associated neuropathy, earning him international recognition. A sought-after educator and mentor, Simpson's contributions continue to shape both the treatment of movement disorders and the training of future neurologists.